| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/12/2009 | US20090068142 Compositions and methods for treating coronavirus infection and sars |
| 03/12/2009 | US20090068141 Autologous natural killer cells and lymphodepleting chemotherapy for the treatment of cancer |
| 03/12/2009 | US20090068140 Hepatitis c virus inhibitors |
| 03/12/2009 | US20090068139 LOOP PEPTIDE AND TGF alpha FOR STIMULATING STEM CELL PROLIFERATION AND MIGRATION |
| 03/12/2009 | US20090068138 Polyglycerol anti-microbial agents and compositions |
| 03/12/2009 | US20090068121 Lantibiotics and uses thereof |
| 03/12/2009 | US20090068107 Enzyme regulating ether lipid signaling pathways |
| 03/12/2009 | US20090068106 selectively inhibit alpha v beta 3 integrin; used in the treatment of diseases associated with angiogenesis and cancer |
| 03/12/2009 | US20090068104 Substantially Homogeneous Bio-Affecting Material Having a Pre-Determined Ratio of Bioaffecting Component to Cell Targeting Component, the Method for Making Such a Material and the Method of its use |
| 03/12/2009 | DE202007018676U1 Einweg-Fußhandtuch Disposable Fußhandtuch |
| 03/12/2009 | CA2711425A1 Antimicrobial activity of bacteriocin-producing lactic acid bacteria |
| 03/12/2009 | CA2698665A1 Pharmaceutical composition for inhibiting amyloid-beta protein accumulation |
| 03/12/2009 | CA2698396A1 Interferon alpha2a modified by polyethylene glycol, the preparation and use thereof |
| 03/12/2009 | CA2698360A1 Compositions comprising yersinia pestis antigens |
| 03/12/2009 | CA2698301A1 Reduction of concomitant infections in pigs by the use of pcv2 antigen |
| 03/12/2009 | CA2698173A1 Interferon alpha 2b modified by polyethylene glycol, the preparation and use thereof |
| 03/12/2009 | CA2697546A1 Phosphadiazine hcv polymerase inhibitors iv |
| 03/12/2009 | CA2697500A1 2,3-substituted azaindole derivatives for treating viral infections |
| 03/12/2009 | CA2697454A1 2-carboxy substituted indole derivatives and methods of use thereof |
| 03/12/2009 | CA2697375A1 2, 3-substituted indole derivatives for treating viral infections |
| 03/12/2009 | CA2696824A1 Compounds and compositions as kinase inhibitors |
| 03/12/2009 | CA2695556A1 Use of carolaction or derivatives thereof to prevent or treat bacterial biofilms |
| 03/12/2009 | CA2690011A1 Dentifrice compositions for treating xerostomia |
| 03/11/2009 | EP2034009A2 Compositions and methods for restoring immune responsiveness in patients with immunological defects basing on cd3/cd28 costimulation |
| 03/11/2009 | EP2033972A1 Screening method for candidate drugs |
| 03/11/2009 | EP2033954A1 6-(heterocycle-substituted benzyl)-4-oxoquinoline compound and use of the same as hiv integrase inhibitor |
| 03/11/2009 | EP2033952A1 Nitrogen-containing Heteroaryl compounds having HIV Integrase Inhibitory Activity |
| 03/11/2009 | EP2033950A1 Substituted tetracycline compounds |
| 03/11/2009 | EP2033655A1 Use of compounds that inhibit the EF-Tu-nucleolin interaction for preventing or treating tularemia |
| 03/11/2009 | EP2033654A1 Macrocyclic isoquinoline peptide inhibitors of hepatitis c virus |
| 03/11/2009 | EP2033648A2 Sustained release drug delivery system containing codrugs |
| 03/11/2009 | EP2033642A1 Pharmaceutical composition effective against biofilms |
| 03/11/2009 | EP2033512A1 Model animal of dendritic cell immunoreceptor gene knockout disease |
| 03/11/2009 | EP2032565A2 Benzisoxazole oxazolidinones as antibacterial agents |
| 03/11/2009 | EP2032167A2 A novel target in the treatment of cytokine release syndrome |
| 03/11/2009 | EP2032165A1 Bioactive purified hspe7 compositions |
| 03/11/2009 | EP1737488B1 Treatment of fungal infections |
| 03/11/2009 | EP1499622B1 Heterotricyclyl 6-alkylidene-penems as beta-lactamase inhibitors |
| 03/11/2009 | EP1485364B1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 03/11/2009 | EP1379550B1 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 03/11/2009 | EP1358165B1 Imidazole derivatives |
| 03/11/2009 | EP1349840B1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 03/11/2009 | EP1317445B1 Chemokine receptor binding heterocyclic compounds |
| 03/11/2009 | EP1221985B1 Conveyance of anti-infective activity to wound dressings |
| 03/11/2009 | EP1165564B1 Process for preparing inhibitors of nucleoside metabolism |
| 03/11/2009 | EP1071763B1 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates |
| 03/11/2009 | EP0988374B1 Hydrophilic composition containing protease produced by vibrio proteolyticus |
| 03/11/2009 | EP0741784B1 Ligand (act-4-l) to a receptor on the surface of activated cd4+ t-cells |
| 03/11/2009 | CN101384714A Novel viral vector |
| 03/11/2009 | CN101384613A Novel antimicrobial peptides and use thereof |
| 03/11/2009 | CN101384604A Ethanol or 1,2-ethanediol cyclohexyl antibiotic derivatives |
| 03/11/2009 | CN101384599A Heterocyclic antiviral compounds |
| 03/11/2009 | CN101384596A Heterocylic antiviral compounds |
| 03/11/2009 | CN101384587A Heterocyclic antiviral compounds |
| 03/11/2009 | CN101384575A Tiglien-3-one derivatives |
| 03/11/2009 | CN101384301A Proteasom or ups inhibitor for treating infections with influenza viruses |
| 03/11/2009 | CN101384271A Use of elderberry extract |
| 03/11/2009 | CN101384269A Use of lactobacillus for treatment of virus infections |
| 03/11/2009 | CN101381757A Solid fermentation preparation method of antibacterial peptide and application |
| 03/11/2009 | CN101381409A N-terminally chemically modified protein compositions and methods |
| 03/11/2009 | CN101381407A Preparation and application of polypeptide medicine for treating mycobacterium tuberculosis infection |
| 03/11/2009 | CN101381386A Lactose-azithromycin hydrate, preparation and use thereof |
| 03/11/2009 | CN101381372A Pazufloxacin mesylate and preparation method of powder for injection |
| 03/11/2009 | CN101381365A Dual action antibiotics |
| 03/11/2009 | CN101381346A Nimorazole derivates for therapy |
| 03/11/2009 | CN101380471A Preparation method of absorption diphtheria tetanus combined vaccine without formaldehyde and merthiolate |
| 03/11/2009 | CN101380470A Pig parvovirus live vaccine |
| 03/11/2009 | CN101380469A Production technique of turbot reddish body iridovirus inactivated vaccine |
| 03/11/2009 | CN101380468A Porcine reproductive and respiratory syndrome bivalence recombinant adenovirus vaccine and preparation method thereof |
| 03/11/2009 | CN101380467A Multi-connection inactivated vaccine (antigen) liquid concentration technique |
| 03/11/2009 | CN101380466A Polypeptide vaccine for treating diseased induced by high pathogenic avian influenza virus H5N1 |
| 03/11/2009 | CN101380463A Composition and its therapeutic use |
| 03/11/2009 | CN101380461A Efficient thymosin enteric-coated tablets and thymosin for injection |
| 03/11/2009 | CN101380460A Preparation method of tea capable of preventing and curing cold |
| 03/11/2009 | CN101380403A Traditional Chinese medicine for treating blue-ear pig disease |
| 03/11/2009 | CN101380389A Production method of tea for preventing encephalitis b |
| 03/11/2009 | CN101380384A Traditional Chinese medicine composition with antibiotic and anti-inflammation action and preparation method and quality control method thereof |
| 03/11/2009 | CN101380376A Wean Qingkailing dispersible tablets |
| 03/11/2009 | CN101380357A Formulations for treating beriberi |
| 03/11/2009 | CN101380355A Medicine for treating beriberi and preparation method thereof |
| 03/11/2009 | CN101380330A Research approach of IFN-alpha anti PCV2 and PRRSV induced by forsythiaside |
| 03/11/2009 | CN101380326A Gluconic acid enoxacin and preparation method of powder and injection preparation thereof |
| 03/11/2009 | CN101380323A Pharmaceutical composition and use thereof |
| 03/11/2009 | CN101380318A Use of isochlorogenic acid compound and different combinations in hepatitis treatment |
| 03/11/2009 | CN101380316A Multifunctional external antibiotic preparation and production method thereof |
| 03/11/2009 | CN101380314A Clindamycin Hydrochloride capsule formulation and production method thereof |
| 03/11/2009 | CN101380302A Potasium dehydroandrographolide succinate injection and production method thereof |
| 03/11/2009 | CN101380301A Compound doxycycline hydrochloride injection for animals and preparation method thereof |
| 03/11/2009 | CN101380300A Compound mequindox injection for animals and preparation method thereof |
| 03/11/2009 | CN100467603C DNA sequences coding for the human proteins TX and TY related to the interleukin-IBeta converting enzyme |
| 03/11/2009 | CN100467600C Compounds and methods for treatment and diagnosis of chlamydial infection |
| 03/11/2009 | CN100467494C Organic medicine and betacyclodextrin derivative and preparation process thereof |
| 03/11/2009 | CN100467481C Antibacterial polypeptide from Amolops loloensis and its pharmaceutical use |
| 03/11/2009 | CN100467476C Derivatives of branched-chain lipophilic molecules and uses thereof |
| 03/11/2009 | CN100467453C 2,6-diamino-3,5-dinitrile-4-aryl pyridine derivative and its synthesis and application |
| 03/11/2009 | CN100467083C Microprojection array immunization patch and method |
| 03/11/2009 | CN100467063C Immunological adjuvant, and its application in preparing vaccine and medicine for anti-virus |
| 03/11/2009 | CN100467062C Method of production of purified hepatitis A virus particles and vaccine preparation |
| 03/11/2009 | CN100467018C Jinlian heat-clearing capsule |
| 03/10/2009 | US7501538 Erythropoietin receptor activators; inducing red blood cell production and maturation |